GlassScriptPhysician profile
James Robert Licht
NPI 1841296506
$1,269.74
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,270.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $305.68 | 2019 | |
| United Therapeutics Corporation | $138.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $121.53 | 2019 | |
| Janssen Pharmaceuticals, INC | $116.61 | 2019 | |
| Gilead Sciences, INC. | $90.32 | 2019 | |
| Sanofi-Aventis U.S. LLC | $82.12 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $80.62 | 2019 | |
| Pfizer INC. | $56.91 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.61 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.61 | 2019 | |
| Boston Scientific Corporation | $34.93 | 2019 | |
| Alnylam Pharmaceuticals INC. | $24.82 | 2019 | |
| Lundbeck LLC | $20.68 | 2019 | |
| Merck Sharp & Dohme LLC | $19.20 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.61 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $16.50 | 2019 | |
| Lemaitre Vascular, INC. | $14.84 | 2019 | |
| Portola Pharmaceuticals, LLC | $13.69 | 2019 | |
| Allergan, INC. | $12.45 | 2019 | |
| Medtronic Vascular, INC. | $11.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.30 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Licht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.